{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:36:53Z","timestamp":1762177013730},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:00:00Z","timestamp":1498176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:00:00Z","timestamp":1498176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growth factor signaling via insulin receptor (IR) and IGF-1 receptor (IGF1R) plays several important roles in the pathogenesis of metabolic syndrome and diabetes. OSI-906 (linsitinib), an anti-tumor drug, is an orally bioavailable dual inhibitor of IR and IGF1R. To investigate the recovery from metabolic changes induced by the acute inhibition of IR and IGF1R in adult mice, mice were treated with OSI-906 or a vehicle for 7 days and the results were analyzed on the last day of injection (Day 7) or after 7 or 21 days of withdrawal (Day 14 or Day 28). On day 7, the visceral white fat mass was significantly reduced in mice treated with OSI-906 accompanied by a reduced expression of leptin and an increased expression of the lipolysis-related genes Lpl and Atgl. Interestingly, the lipoatrophy and the observed changes in gene expression were completely reversed on day 14. Similarly, liver steatosis and \u03b2 cell proliferation were transiently observed on day 7 but had disappeared by day 14. Taken together, these results suggest that this model for the acute inhibition of systemic IR\/IGF1R signaling may be useful for investigating the recovery from metabolic disorders induced by impaired growth factor signaling.<\/jats:p>","DOI":"10.1038\/s41598-017-04304-5","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T08:29:11Z","timestamp":1497860951000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic \u03b2 cell proliferation after the withdrawal of OSI-906"],"prefix":"10.1038","volume":"7","author":[{"given":"Kazuki","family":"Tajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Kyohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Terauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"key":"4304_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","volume":"23","author":"GF Lewis","year":"2002","unstructured":"Lewis, G. F., Carpentier, A., Adeli, K. & Giacca, A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev \n                           23, 201\u2013229, doi:10.1210\/edrv.23.2.0461 (2002).","journal-title":"Endocr Rev"},{"key":"4304_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1651-2227.1996.tb14262.x","volume":"413","author":"M Seip","year":"1996","unstructured":"Seip, M. & Trygstad, O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl \n                           413, 2\u201328 (1996).","journal-title":"Acta Paediatr Suppl"},{"issue":"Suppl 1","key":"4304_CR3","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","volume":"17","author":"A Carr","year":"2003","unstructured":"Carr, A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS \n                           17(Suppl 1), S141\u2013148 (2003).","journal-title":"AIDS"},{"key":"4304_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jaad.2006.05.005","volume":"55","author":"E Pope","year":"2006","unstructured":"Pope, E., Janson, A., Khambalia, A. & Feldman, B. Childhood acquired lipodystrophy: a retrospective study. J Am Acad Dermatol \n                           55, 947\u2013950, doi:10.1016\/j.jaad.2006.05.005 (2006).","journal-title":"J Am Acad Dermatol"},{"key":"4304_CR5","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","volume":"87","author":"A Seppala-Lindroos","year":"2002","unstructured":"Seppala-Lindroos, A. et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab \n                           87, 3023\u20133028, doi:10.1210\/jcem.87.7.8638 (2002).","journal-title":"J Clin Endocrinol Metab"},{"key":"4304_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2337\/diabetes.51.2.301","volume":"51","author":"P Shah","year":"2002","unstructured":"Shah, P. et al. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes \n                           51, 301\u2013310 (2002).","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"4304_CR7","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.2337\/diabetes.50.2007.S154","volume":"50","author":"GC Weir","year":"2001","unstructured":"Weir, G. C., Laybutt, D. R., Kaneto, H., Bonner-Weir, S. & Sharma, A. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes \n                           50(Suppl 1), S154\u2013159 (2001).","journal-title":"Diabetes"},{"key":"4304_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.beem.2005.07.011","volume":"19","author":"S Bluher","year":"2005","unstructured":"Bluher, S., Kratzsch, J. & Kiess, W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab \n                           19, 577\u2013587, doi:10.1016\/j.beem.2005.07.011 (2005).","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4304_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ng1787","volume":"38","author":"K Ueki","year":"2006","unstructured":"Ueki, K. et al. Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. Nat Genet \n                           38, 583\u2013588, doi:10.1038\/ng1787 (2006).","journal-title":"Nat Genet"},{"key":"4304_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1172\/JCI0215276","volume":"110","author":"S Xuan","year":"2002","unstructured":"Xuan, S. et al. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest \n                           110, 1011\u20131019, doi:10.1172\/jci15276 (2002).","journal-title":"J Clin Invest"},{"key":"4304_CR11","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1152\/ajpendo.00533.2001","volume":"286","author":"K Otani","year":"2004","unstructured":"Otani, K. et al. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab \n                           286, E41\u201349, doi:10.1152\/ajpendo.00533.2001 (2004).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4304_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1474-9726.2007.00346.x","volume":"6","author":"M Katic","year":"2007","unstructured":"Katic, M. et al. Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell \n                           6, 827\u2013839, doi:10.1111\/j.1474-9726.2007.00346.x (2007).","journal-title":"Aging Cell"},{"key":"4304_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0092-8674(00)80546-2","volume":"96","author":"RN Kulkarni","year":"1999","unstructured":"Kulkarni, R. N. et al. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell \n                           96, 329\u2013339 (1999).","journal-title":"Cell"},{"key":"4304_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/ncomms1905","volume":"3","author":"J Boucher","year":"2012","unstructured":"Boucher, J. et al. Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nat Commun \n                           3, 902, doi:10.1038\/ncomms1905 (2012).","journal-title":"Nat Commun"},{"key":"4304_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","volume":"6","author":"MD Michael","year":"2000","unstructured":"Michael, M. D. et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell \n                           6, 87\u201397 (2000).","journal-title":"Mol Cell"},{"key":"4304_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1534-5807(02)00199-5","volume":"3","author":"M Bluher","year":"2002","unstructured":"Bluher, M. et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell \n                           3, 25\u201338 (2002).","journal-title":"Dev Cell"},{"key":"4304_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng872","volume":"31","author":"RN Kulkarni","year":"2002","unstructured":"Kulkarni, R. N. et al. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet \n                           31, 111\u2013115, doi:10.1038\/ng872 (2002).","journal-title":"Nat Genet"},{"key":"4304_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0196-106","volume":"12","author":"D Accili","year":"1996","unstructured":"Accili, D. et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet \n                           12, 106\u2013109, doi:10.1038\/ng0196-106 (1996).","journal-title":"Nat Genet"},{"key":"4304_CR19","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/j.1460-2075.1996.tb00498.x","volume":"15","author":"RL Joshi","year":"1996","unstructured":"Joshi, R. L. et al. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. Embo Journal \n                           15, 1542\u20131547 (1996).","journal-title":"Embo Journal"},{"key":"4304_CR20","first-page":"59","volume":"75","author":"JP Liu","year":"1993","unstructured":"Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J. & Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell \n                           75, 59\u201372 (1993).","journal-title":"Cell"},{"key":"4304_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4155\/fmc.09.89","volume":"1","author":"MJ Mulvihill","year":"2009","unstructured":"Mulvihill, M. J. et al. Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. Future Med Chem \n                           1, 1153\u20131171, doi:10.4155\/fmc.09.89 (2009).","journal-title":"Future Med Chem"},{"key":"4304_CR22","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1002\/cncr.26656","volume":"118","author":"WY Kim","year":"2012","unstructured":"Kim, W. Y. et al. Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors. Cancer \n                           118, 3993\u20134003, doi:10.1002\/cncr.26656 (2012).","journal-title":"Cancer"},{"key":"4304_CR23","doi-asserted-by":"publisher","first-page":"37120","DOI":"10.1038\/srep37120","volume":"6","author":"D Poburski","year":"2016","unstructured":"Poburski, D. et al. Insulin-IGF signaling affects cell transformation in the BALB\/c 3T3 cell model. Scientific reports \n                           6, 37120, doi:10.1038\/srep37120 (2016).","journal-title":"Scientific reports"},{"key":"4304_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1158\/1078-0432.CCR-14-0303","volume":"21","author":"I Puzanov","year":"2015","unstructured":"Puzanov, I. et al. A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors. Clin Cancer Res \n                           21, 701\u2013711, doi:10.1158\/1078-0432.ccr-14-0303 (2015).","journal-title":"Clin Cancer Res"},{"key":"4304_CR25","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1210\/en.2013-2032","volume":"155","author":"J Shirakawa","year":"2014","unstructured":"Shirakawa, J. et al. Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, beta-cell functions, and beta-cell proliferation in male mice. Endocrinology \n                           155, 2102\u20132111, doi:10.1210\/en.2013-2032 (2014).","journal-title":"Endocrinology"},{"key":"4304_CR26","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","volume":"87","author":"WA Haque","year":"2002","unstructured":"Haque, W. A., Shimomura, I., Matsuzawa, Y. & Garg, A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab \n                           87, 2395, doi:10.1210\/jcem.87.5.8624 (2002).","journal-title":"J Clin Endocrinol Metab"},{"key":"4304_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/43448","volume":"401","author":"I Shimomura","year":"1999","unstructured":"Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S. & Goldstein, J. L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature \n                           401, 73\u201376, doi:10.1038\/43448 (1999).","journal-title":"Nature"},{"key":"4304_CR28","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.2337\/diabetes.49.11.1880","volume":"49","author":"N Kubota","year":"2000","unstructured":"Kubota, N. et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes \n                           49, 1880\u20131889 (2000).","journal-title":"Diabetes"},{"key":"4304_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/1357-2725(96)00005-2","volume":"28","author":"KM Kelley","year":"1996","unstructured":"Kelley, K. M. et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol \n                           28, 619\u2013637 (1996).","journal-title":"Int J Biochem Cell Biol"},{"key":"4304_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cell.2013.04.008","volume":"153","author":"P Yi","year":"2013","unstructured":"Yi, P., Park, J. S. & Melton, D. A. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell \n                           153, 747\u2013758, doi:10.1016\/j.cell.2013.04.008 (2013).","journal-title":"Cell"},{"key":"4304_CR31","doi-asserted-by":"publisher","unstructured":"El Ouaamari, A. et al. SerpinB1 Promotes Pancreatic beta Cell Proliferation. Cell Metab, doi:10.1016\/j.cmet.2015.12.001 (2015).","DOI":"10.1016\/j.cmet.2015.12.001"},{"key":"4304_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1210\/jc.2006-1546","volume":"92","author":"K Ebihara","year":"2007","unstructured":"Ebihara, K. et al. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab \n                           92, 532\u2013541, doi:10.1210\/jc.2006-1546 (2007).","journal-title":"J Clin Endocrinol Metab"},{"key":"4304_CR33","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.2337\/db07-1538","volume":"57","author":"N Kloting","year":"2008","unstructured":"Kloting, N. et al. Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes \n                           57, 2074\u20132082, doi:10.2337\/db07-1538 (2008).","journal-title":"Diabetes"},{"key":"4304_CR34","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1210\/en.2012-1165","volume":"153","author":"J Shirakawa","year":"2012","unstructured":"Shirakawa, J. et al. Effects of liraglutide on beta-cell-specific glucokinase-deficient neonatal mice. Endocrinology \n                           153, 3066\u20133075, doi:10.1210\/en.2012-1165 (2012).","journal-title":"Endocrinology"},{"key":"4304_CR35","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1073\/pnas.0801981105","volume":"105","author":"MY Wang","year":"2008","unstructured":"Wang, M. Y. et al. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc Natl Acad Sci USA \n                           105, 6139\u20136144, doi:10.1073\/pnas.0801981105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"4304_CR36","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest \n                           115, 1343\u20131351, doi:10.1172\/jci23621 (2005).","journal-title":"J Clin Invest"},{"key":"4304_CR37","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.2337\/db13-0052","volume":"62","author":"J Shirakawa","year":"2013","unstructured":"Shirakawa, J. et al. Glucokinase activation ameliorates ER stress-induced apoptosis in pancreatic beta-cells. Diabetes \n                           62, 3448\u20133458, doi:10.2337\/db13-0052 (2013).","journal-title":"Diabetes"},{"key":"4304_CR38","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1172\/JCI79264","volume":"125","author":"RB Sharma","year":"2015","unstructured":"Sharma, R. B. et al. Insulin demand regulates beta cell number via the unfolded protein response. J Clin Invest \n                           125, 3831\u20133846, doi:10.1172\/jci79264 (2015).","journal-title":"J Clin Invest"},{"key":"4304_CR39","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1210\/en.2013-1796","volume":"155","author":"Y Togashi","year":"2014","unstructured":"Togashi, Y. et al. beta-Cell proliferation after a partial pancreatectomy is independent of IRS-2 in mice. Endocrinology \n                           155, 1643\u20131652, doi:10.1210\/en.2013-1796 (2014).","journal-title":"Endocrinology"},{"key":"4304_CR40","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s00125-015-3670-0","volume":"58","author":"Y Xu","year":"2015","unstructured":"Xu, Y. et al. Prolactin-stimulated survivin induction is required for beta cell mass expansion during pregnancy in mice. Diabetologia \n                           58, 2064\u20132073, doi:10.1007\/s00125-015-3670-0 (2015).","journal-title":"Diabetologia"},{"key":"4304_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2337\/db09-0838","volume":"59","author":"S Georgia","year":"2010","unstructured":"Georgia, S. et al. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes \n                           59, 987\u2013996, doi:10.2337\/db09-0838 (2010).","journal-title":"Diabetes"},{"key":"4304_CR42","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.1210\/endo.136.12.7588296","volume":"136","author":"L Scaglia","year":"1995","unstructured":"Scaglia, L., Smith, F. E. & Bonner-Weir, S. Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology \n                           136, 5461\u20135468, doi:10.1210\/endo.136.12.7588296 (1995).","journal-title":"Endocrinology"},{"key":"4304_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1210\/jcem.85.2.6392","volume":"85","author":"F Andreelli","year":"2000","unstructured":"Andreelli, F. et al. Normal reproductive function in leptin-deficient patients with lipoatropic diabetes. J Clin Endocrinol Metab \n                           85, 715\u2013719, doi:10.1210\/jcem.85.2.6392 (2000).","journal-title":"J Clin Endocrinol Metab"},{"key":"4304_CR44","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","volume":"12","author":"I Shimomura","year":"1998","unstructured":"Shimomura, I. et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev \n                           12, 3182\u20133194 (1998).","journal-title":"Genes Dev"},{"key":"4304_CR45","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","volume":"50","author":"K Ebihara","year":"2001","unstructured":"Ebihara, K. et al. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes \n                           50, 1440\u20131448 (2001).","journal-title":"Diabetes"},{"key":"4304_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cmet.2006.09.005","volume":"4","author":"SD Covey","year":"2006","unstructured":"Covey, S. D. et al. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab \n                           4, 291\u2013302, doi:10.1016\/j.cmet.2006.09.005 (2006).","journal-title":"Cell Metab"},{"key":"4304_CR47","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1172\/JCI30910","volume":"117","author":"T Morioka","year":"2007","unstructured":"Morioka, T. et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest \n                           117, 2860\u20132868, doi:10.1172\/JCI30910 (2007).","journal-title":"J Clin Invest"},{"key":"4304_CR48","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Bruning","year":"2000","unstructured":"Bruning, J. C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science \n                           289, 2122\u20132125 (2000).","journal-title":"Science"},{"key":"4304_CR49","doi-asserted-by":"publisher","first-page":"25467","DOI":"10.1074\/jbc.M110.217216","volume":"286","author":"J Shirakawa","year":"2011","unstructured":"Shirakawa, J. et al. Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased beta cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes. J Biol Chem \n                           286, 25467\u201325476, doi:10.1074\/jbc.M110.217216 (2011).","journal-title":"J Biol Chem"},{"key":"4304_CR50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/acel.12201","volume":"13","author":"V Menon","year":"2014","unstructured":"Menon, V. et al. The contribution of visceral fat to improved insulin signaling in Ames dwarf mice. Aging Cell \n                           13, 497\u2013506, doi:10.1111\/acel.12201 (2014).","journal-title":"Aging Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04304-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04304-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04304-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:51:44Z","timestamp":1671774704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04304-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["4304"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-04304-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,23]]},"assertion":[{"value":"15 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4119"}}